Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BACKNASDAQ:BGLCNASDAQ:BTTXNASDAQ:NIVF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBACKIMAC$0.05+10.1%$0.04$0.03▼$2.94$104K2.07435,766 shs1,855 shsBGLCBioNexus Gene Lab$2.87-2.0%$2.96$2.01▼$8.40$5.17M5.6279,965 shs19,421 shsBTTXBetter Therapeutics$0.00$0.00$0.00▼$0.03$5K0.9517,283 shs1,000 shsNIVFNewGenIvf Group$1.20-3.2%$2.71$1.16▼$656.00$636K0.14814,197 shs332,678 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBACKIMAC0.00%+17.65%+51.52%-88.16%-97.99%BGLCBioNexus Gene Lab0.00%+3.99%-2.38%-0.31%-37.99%BTTXBetter Therapeutics0.00%0.00%0.00%-75.00%-98.51%NIVFNewGenIvf Group0.00%-29.41%-54.55%-88.89%-99.43%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBACKIMACN/AN/AN/AN/AN/AN/AN/AN/ABGLCBioNexus Gene LabN/AN/AN/AN/AN/AN/AN/AN/ABTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ANIVFNewGenIvf GroupN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBACKIMAC 0.00N/AN/AN/ABGLCBioNexus Gene Lab 0.00N/AN/AN/ABTTXBetter Therapeutics 0.00N/AN/AN/ANIVFNewGenIvf Group 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBACKIMAC$72.05K1.44N/AN/A($0.66) per share-0.08BGLCBioNexus Gene Lab$9.51M0.54N/AN/A$4.63 per share0.62BTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/ANIVFNewGenIvf Group$5.43M0.12N/AN/A($29.20) per share-0.04Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBACKIMAC-$9.42MN/A0.00∞N/AN/AN/A-325.44%8/4/2025 (Estimated)BGLCBioNexus Gene Lab-$1.60MN/A0.00∞N/A-22.85%-24.18%-20.14%N/ABTTXBetter Therapeutics-$39.76MN/A0.00∞N/AN/AN/AN/A7/21/2025 (Estimated)NIVFNewGenIvf Group-$520KN/A0.00∞N/AN/AN/AN/AN/ALatest BGLC, NIVF, BACK, and BTTX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025BGLCBioNexus Gene LabN/A-$0.03N/A-$0.03N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBACKIMACN/AN/AN/AN/AN/ABGLCBioNexus Gene LabN/AN/AN/AN/AN/ABTTXBetter TherapeuticsN/AN/AN/AN/AN/ANIVFNewGenIvf GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBACKIMACN/A0.080.08BGLCBioNexus Gene LabN/A4.193.44BTTXBetter TherapeuticsN/AN/AN/ANIVFNewGenIvf GroupN/A1.171.14Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBACKIMAC5.84%BGLCBioNexus Gene Lab18.85%BTTXBetter Therapeutics34.00%NIVFNewGenIvf Group66.24%Insider OwnershipCompanyInsider OwnershipBACKIMAC12.26%BGLCBioNexus Gene Lab0.70%BTTXBetter Therapeutics51.40%NIVFNewGenIvf Group31.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBACKIMAC1802.07 million1.82 millionNot OptionableBGLCBioNexus Gene Lab301.80 million1.78 millionNot OptionableBTTXBetter Therapeutics4049.86 million24.23 millionOptionableNIVFNewGenIvf GroupN/A530,000359,000N/ABGLC, NIVF, BACK, and BTTX HeadlinesRecent News About These CompaniesNewGenIvf Group Expands Share Base with Strategic IssuancesJune 20 at 5:31 PM | tipranks.comNewGenIvf Group to Present Digital Asset Updates at Emerging Growth ConferenceJune 17, 2025 | tipranks.comNewGen announces $45 million strategic investment in UAE real estate marketJune 12, 2025 | kalkinemedia.comNewGen Announces Planned US$45 Million Strategic Investment in UAE Real Estate MarketJune 12, 2025 | globenewswire.comBRIEF-NewGenIvf Group Files For Offering Of 22.02 Million Class A Ordinary Shares By Selling StockholdersJune 5, 2025 | sg.finance.yahoo.comNewGenIvf Group Announces Planned $30M Strategic Investment in Solana StakingJune 4, 2025 | uk.investing.comNewGenIvf Plans To Invest $30 Mln In SolanaJune 4, 2025 | nasdaq.comNewGenIvf Group Secures $3.2 Million in Debt FinancingJune 4, 2025 | tipranks.comNewGenIvf Group Ltd.June 2, 2025 | wsj.comNewGen Doubles Down on Solana with $30 Million SOL Staking StrategyJune 2, 2025 | coingape.comNewGenIvf Group Limited Announces $30 Million Investment in Solana to Expand Digital Asset StrategyJune 2, 2025 | quiverquant.comNewGen Announces Planned $30 Million Strategic Investment in Solana Digital Asset StakingJune 2, 2025 | globenewswire.comNIVF NewGenIvf Group LimitedMay 30, 2025 | seekingalpha.comNewGen Announces Strategic Expansion with Services Tailored for Indian Medical TouristsMay 27, 2025 | finance.yahoo.comNewGenIVF Introduces NewGenSort to Support Men’s Reproductive Health Across AsiaMay 7, 2025 | finance.yahoo.comNewGenIVF Announces Reverse Stock SplitMay 1, 2025 | globenewswire.comNewGenIvf Group reports FY24 EPS (64c) vs. $3.53 last yearApril 23, 2025 | markets.businessinsider.comNewGenIvf Group Limited Files Annual Report for Fiscal Year 2024, Highlights Strong Financial PositionApril 22, 2025 | quiverquant.comNewGen Filed 2024 Annual Report on Form 20-FApril 22, 2025 | globenewswire.comBRIEF-Newgenivf Group-On April 15, Approved Reverse Stock Split Of All Of Co’S Issued And Unissued SharesApril 16, 2025 | sg.finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Penny Stocks Analysts Believe Are Headed HigherBy Chris Markoch | June 4, 2025View 3 Penny Stocks Analysts Believe Are Headed HigherSuper Micro Computer Stock's Rally Backed by Strong FinancialsBy Gabriel Osorio-Mazilli | June 19, 2025View Super Micro Computer Stock's Rally Backed by Strong FinancialsUber Stock Ready to Ride Higher on Waymo PartnershipBy Gabriel Osorio-Mazilli | May 28, 2025View Uber Stock Ready to Ride Higher on Waymo PartnershipAmazon Is on Track to Hit a Critical Level: Watch OutBy Sam Quirke | June 11, 2025View Amazon Is on Track to Hit a Critical Level: Watch OutThese 3 Stocks Are Buying Back Billions in SharesBy Leo Miller | June 3, 2025View These 3 Stocks Are Buying Back Billions in SharesBGLC, NIVF, BACK, and BTTX Company DescriptionsIMAC NASDAQ:BACK$0.05 +0.00 (+10.13%) As of 06/20/2025 03:43 PM EasternIMAC Holdings, Inc. owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides medical treatments, regenerative, spinal decompression, chiropractic manipulation, and physical medicine and therapy. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Franklin, Tennessee.BioNexus Gene Lab NASDAQ:BGLC$2.87 -0.06 (-2.05%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$2.77 -0.10 (-3.45%) As of 06/20/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.Better Therapeutics NASDAQ:BTTX$0.0001 0.00 (0.00%) As of 06/20/2025 03:33 PM EasternBetter Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.NewGenIvf Group NASDAQ:NIVF$1.20 -0.04 (-3.23%) Closing price 06/20/2025 04:00 PM EasternExtended Trading$1.23 +0.03 (+2.08%) As of 07:23 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
